| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $114.2M | — | +0.2% |
| R&D Expense | $27.1M | — | -31.5% |
| SG&A Expense | $41.8M | — | -14.2% |
| Operating Income | $2.2M | — | +113.1% |
| Interest Expense | $678K | — | -7.4% |
| Pre-tax Income | $2.3M | — | +115.4% |
| Income Tax | $10.1M | — | +190.0% |
| Net Income | -$7.8M | — | +57.4% |
| EPS (Basic) | -$0.17 | — | +58.5% |
| EPS (Diluted) | -$0.17 | — | +58.5% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $70.4M | -27.3% | -20.0% |
| Accounts Receivable | $59.9M | +5.4% | +2.9% |
| Current Assets | $260.9M | -2.5% | -2.2% |
| Total Assets | $606.9M | -1.4% | -4.2% |
| Current Liabilities | $110.4M | -0.3% | -6.3% |
| Long-term Debt | $27.7M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$18.0M | — | +19.1% |
| Capital Expenditures | $1.1M | — | +3.7% |
| Investing Cash Flow | -$4.8M | — | -14.9% |
| Financing Cash Flow | -$3.6M | — | +77.9% |
| Free Cash Flow | -$19.1M | — | +18.0% |
| +0.0% |
| Total Liabilities | $198.9M | -1.4% | -7.3% |
| Stockholders' Equity | $408.0M | -1.5% | -2.6% |